Stefano Amendola
Overview
Explore the profile of Stefano Amendola including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
231
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wolde Sellasie S, Amendola S, Guidobaldi L, Piticchio T, Nardone I, Zaccaria S, et al.
Updates Surg
. 2025 Feb;
PMID: 40009136
Identifying preoperatively cases of more indolent papillary thyroid carcinoma (PTC)could be of high interest. The aim of this study was to verify previously published data on the prognostic value of...
2.
Wolde Sellasie S, Amendola S, Guidobaldi L, Pedicini F, Nardone I, Piticchio T, et al.
Diagn Cytopathol
. 2025 Jan;
PMID: 39797433
The measurement of Calcitonin (Ctn) in fine-needle aspiration (FNA) washout fluids (FNA-Ctn) has demonstrated excellent sensitivity, significantly higher than FNA cytology, in detecting medullary thyroid carcinoma (MTC). However, the absence...
3.
Giusto C, Passeri M, Sperti P, Nardone I, Wolde Sellasie S, Zaccaria S, et al.
Endocr Metab Immune Disord Drug Targets
. 2024 Aug;
PMID: 39192655
Background: Resistance to thyroid hormone is a rare syndrome characterized by peripheral resistance to thyroid hormones. It is caused by genetic dysfunction of thyroid receptor genes, with Thyroid hormone Receptor-beta...
4.
Nardone I, Wolde Sellasie S, Cinque A, Tacchi G, Zaccaria S, Giusto C, et al.
Endocr Metab Immune Disord Drug Targets
. 2024 Aug;
PMID: 39108109
Background: Patients with permanent hypoparathyroidism experience an impaired quality of life, due to acute and chronic complications that may affect several organs, with an increased risk of hospitalisation and death....
5.
Amendola S, Piticchio T, Scappaticcio L, Wolde Sellasie S, Volpe S, Le Moli R, et al.
Updates Surg
. 2024 Mar;
76(3):1055-1061.
PMID: 38446376
The incidence of papillary thyroid carcinoma (PTC) is increasing and PTC ≤ 10 mm (PTMC) accounts for most new diagnoses. PTMCs are not always low risk, as detection of lymph...
6.
Amendola S, Wolde Sellasie S, Pedicini F, Carlini M, Russo G, Ossola N, et al.
J Clin Med
. 2023 Jan;
12(2).
PMID: 36675326
Background: Several US risk stratification score systems (RSSs) have been developed to standardize a thyroid nodule risk of malignancy. It is still a matter of debate which RSS is the...
7.
Pasini A, Racca P, Amendola S, Cartocci G, Cassardo C
Sci Rep
. 2017 Dec;
7(1):17681.
PMID: 29247168
Attribution studies on recent global warming by Global Climate Model (GCM) ensembles converge in showing the fundamental role of anthropogenic forcings as primary drivers of temperature in the last half...
8.
Festuccia F, Jafari M, Moioli A, Fofi C, Barberi S, Amendola S, et al.
J Nephrol
. 2016 Jul;
30(2):271-279.
PMID: 27394428
Background And Aims: In elderly subjects, renal insufficiency and osteoporosis often coexist with high risk of fracture and elevated socio-economic burden. Today a large number of effective anti-osteoporotic drugs are...
9.
Sciacchitano S, Lavra L, Ulivieri A, Magi F, Porcelli T, Amendola S, et al.
Endocrine
. 2015 Oct;
54(1):139-147.
PMID: 26475496
The use of galectin-3 ThyroTest in the preoperative evaluation of cytologically indeterminate (Thy-3) thyroid nodules has been largely validated by retrospective and prospective multicentre studies. Here we report the results...
10.
Trimboli P, Nasrollah N, Amendola S, Crescenzi A, Guidobaldi L, Chiesa C, et al.
Gland Surg
. 2015 Aug;
4(4):307-11.
PMID: 26312216
Background: Twenty percent of thyroid fine needle aspiration (FNA) is indeterminate. Because 3 in 4 of these are actually benign, a method of clarifying the pathology could help patients to...